
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
A first-in-class saliva test for COVID-19 detection, the first oral immunotherapy for peanut allergies, and 7 more new drugs PCPs should know about.
At the close of the first quarter of a new decade, Patient Care® Online has compiled a list of 9 new FDA-approved drugs for conditions that are often seen in primary care. Scroll through the slides below to find details on the first intravenous calcitonin gene-related peptide blocker for migraine prevention; the first and only oral immunotherapy for peanut allergies; a first-in-class collection method that utilizes saliva as the primary test biomaterial for COVID-19; and 6 more.






